The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast - 2009/06/26 - Business Insights

Report title: The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast

from Business Insights
142 page report published Jun 26, 2009

Price $3,835.00 available for immediate download

Report Overview

Table of Contents

Search Inside

About Business Insights

India's per capita healthcare expenditure is well below international recommendations and compares poorly with the other emerging economies (Brazil, Russian Federation, China, Republic of Korea, Turkey and Mexico). Despite an improvement in the country's healthcare infrastructure over the recent past, there remains a lack of health centers and shortage of health personnel. India has an extensive healthcare system, reaching even remote areas, yet the country's performance on health indicators remains low. Consequently, private healthcare services have been growing. Publicprivate partnerships have also grown, and represent a promising option which also deals with some of the welfare goals of the state. These partnerships are forged with the objective of improving the quality and efficiency of healthcare delivery while maintaining accessibility and availability for all. Success rate of such initiatives has been variable across states thus far, yet this is a trend set to stay in the country's healthcare system. As per the 2008 sales figures, the Indian pharmaceutical market currently ranks 13th among the major global markets, with sales of $7.7bn in 2008. Yet the promise that the country's pharmaceutical market holds for the long term is much bigger even though its economy has been growing at a slower rate than China. The Indian Pharmaceutical Market Outlook to 2014' provides comprehensive coverage of the Indian pharmaceutical market, incorporating the market structure, pricing and regulation and detailed analyses of the leading companies and likely healthcare reforms. The report makes a wide-ranging assessment of the marketed product portfolios, R&D pipelines, market share data, sales forecast and competitive landscape of the major players in the Indian market. Furthermore, it highlights the key market and R&D trends that may influence treatment sales, with a thorough analysis of the competitive dynamics of leading brands within the country and across different indications, in order to enable the reader to identify growth trends, key drug classes and leading players through to 2014.Key findingsPrivate healthcare systems have been growing in the country due to the rising income levels of people and the inefficiencies of the public systems. The qualified pool of doctors and the advanced infrastructure of these private medical facilities at costs significantly below the developed countries, has positioned India at a strategically advantageous position to grow as a medical tourism hub. India's rapidly growing middle class and the ageing population make it an attractive investment destination. The pharmaceutical market is expected to grow at a CAGR of 12.3% through 2014 which could even surpass other emerging economies such as China. In 1972, a law was passed in India that allowed local manufacturers to manufacture drugs that were still patent protected, with the use of alternative processes. Such a patent regime, though non-compliant with international standards, provided a boost to the local generics industry which could provide drugs both locally and to other emerging markets. In light of the increasing pricing pressures on the global pharmaceutical industry and a newly found emphasis on generics in countries such as the US, leading global players have been strategizing to evolve an all-new hybrid business model in line with the Novartis'Sandoz model. Use this report to
- Develop an understanding of the Indian healthcare system and the issues facing it.
- Understand the IP laws in India and how they affect the local and global pharmaceutical industry.
- Discover the new strategies and evolving new business models that companies are developing in order to sustain profitability in the new economic and political climate.
- Gain up-to-date competitive intelligence and understand the major issues affecting the leading pharmaceutical companies.
- Compare the franchises of top pharmaceut

Source:

Business Insights

Document ID:

rbhc0230

Industry:

Biotechnology

Industry:

Pharmaceutical

Free Sample:

Click Here to Download

Format:

PDF

Title	Starting Page	Number of Pages
Sections
Table of Contents The Indian Pharmaceutical Market Outlook to 2014 Executive summary 10 Overview of India 10 The Indian healthcare system 11 The pharmaceutical industry in India 12 Key players in the Indian pharmaceutical market 13 Indian pharmaceutical ma	0	1
Table of Contents	0	1
The Indian Pharmaceutical Market Outlook to 2014	0	1
Executive summary 10	0	1
Overview of India 10	0	1
The Indian healthcare system 11	0	1
The pharmaceutical industry in India 12	0	1
Key players in the Indian pharmaceutical market 13	0	1
Indian pharmaceutical market SWOT analysis 14	0	1
Chapter 1 Scope and methodology 16	0	1
Scope 16	0	1
Methodology 16	0	1
Scope of IMS data 17	0	1
Chapter 2 Overview of India 20	0	1
Summary 20	0	1
Introduction 21	0	1
Overview of Indian history 21	0	1
The government 21	0	1
A burgeoning economy 22	0	1
Key economic parameters 23	0	1
An imprint of the global slowdown 24	0	1
Population profile and demographic trends 26	0	1
Disease burden 27	0	1
Vector-borne diseases 31	0	1
Chapter 3 The Indian healthcare system 34	0	1
Summary 34	0	1
Introduction 35	0	1
Healthcare system 37	0	1
The rural healthcare system 38	0	1
The urban healthcare system 39	0	1
Specialist and emergency medical care 40	0	1
The regulatory set-up 41	0	1
Intellectual property rights 41	0	1
Effect of IPR regime on innovation 42	0	1
Financing healthcare 43	0	1
Inefficiencies fueled by underutilization of funds 45	0	1
Pricing and reimbursement 46	0	1
Private health insurance 47	0	1
Private healthcare 49	0	1
A range of private healthcare services 50	0	1
Public-private partnerships 50	0	1
Alternative medicine: AYUSH 51	0	1
Ayurveda 51	0	1
Yoga 52	0	1
Naturopathy 52	0	1
Unani 52	0	1
Siddha 53	0	1
Homoeopathy 53	0	1
Chapter 4 The pharmaceutical market in India 56	0	1
Summary 56	0	1
Introduction 57	0	1
Key market trends, events and issues 59	0	1
Therapy area analysis 64	0	1
Therapy area sales forecast 74	0	1
Leading brands 75	0	1
Leading brands sales forecast 79	0	1
Over-the-counter medication 80	0	1
The Indian generics advantage 80	0	1
Chapter 5 Key players in the Indian pharmaceutical market 84	0	1
Summary 84	0	1
Introduction 85	0	1
Leading players of the Indian pharmaceutical market 86	0	1
Detailed analysis of the Indian pharmaceutical market players 87	0	1
Cipla 87	0	1
Overview 87	0	1
Sales focus by leading drug classes 88	0	1
Sales focus by leading brands 91	0	1
New product launches 92	0	1
SWOT analysis 94	0	1
Strengths 94	0	1
Weaknesses 95	0	1
Opportunities 96	0	1
Threats 96	0	1
Ranbaxy 97	0	1
Overview 97	0	1
Sales focus by leading drug classes 97	0	1
Sales focus by leading brands 99	0	1
R&D pipeline analysis 101	0	1
SWOT analysis 103	0	1
Strengths 103	0	1
Weaknesses 104	0	1
Opportunities 105	0	1
Threats 106	0	1
GlaxoSmithKline (India) 106	0	1
Overview 106	0	1
Sales focus by leading drug classes 107	0	1
Sales focus by leading brands 108	0	1
R&D pipeline analysis 111	0	1
SWOT analysis 112	0	1
Strengths 112	0	1
Weaknesses 113	0	1
Opportunities 113	0	1
Threats 115	0	1
Piramal Healthcare 115	0	1
Overview 115	0	1
Sales focus by leading drug classes 115	0	1
Sales focus by leading brands 117	0	1
R&D pipeline analysis 119	0	1
SWOT analysis 120	0	1
Strengths 120	0	1
Weaknesses 122	0	1
Opportunities 122	0	1
Threats 123	0	1
Zydus Cadila 123	0	1
Overview 123	0	1
Sales focus by leading drug classes 124	0	1
Sales focus by leading brands 125	0	1
R&D pipeline analysis 126	0	1
SWOT analysis 127	0	1
Strengths 127	0	1
Weaknesses 128	0	1
Opportunities 128	0	1
Threats 129	0	1
A snapshot of other key market players 129	0	1
Sun Pharma 129	0	1
Lupin 130	0	1
Alkem 131	0	1
Sanofi-Aventis 132	0	1
Mankind Pharma 133	0	1
Leading players in the Indian pharmaceutical market: sales forecast 134	0	1
Chapter 6 Appendix 136	0	1
IMS data 136	0	1
Anatomical Therapeutic Classification (ATC) 136	0	1
A: Alimentary tract and metabolism 136	0	1
B: Blood and blood-forming organs 136	0	1
C: Cardiovascular system 136	0	1
D: Dermatologicals 137	0	1
G: Genito-urinary system and sex hormones 137	0	1
H: Systemic hormonal preparations 137	0	1

Enter the keyword(s) which you would like to search for within this document and click "Search"

Business Insights provides a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors.

Price: $3,835.00

Free Sample

Questions about
this research?

Send page to a friend

Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.